ChromaDex (CDXC) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil prices set for weekly fall on easing fears over Saudi supply disruption
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
ChromaDex Corporation Reports Second Quarter 2021 Financial Results
August 3, 2021 4:02 PM EDTTru Niagen® net sales of $15.4 million for the three months ended June 30, 2021, up 31% from the prior year quarter, with total company net sales of $17.7 million and gross margin of 61.1% for the quarter.
LOS ANGELES--(BUSINESS WIRE)-- ChromaDex Corp. (NASDAQ: CDXC) today announced financial results for the second quarter of 2021.
Second Quarter 2021 and Recent Highlights
Total net sales were $17.7 million, up 16% from the prior year quarter. Tru Niagen® net sales were $15.4 million, a 31% increase from the prior year quarter. Gross... More